Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
2.

[Monitoring age-dependent effect of anticoagulation treatment in patients with atrial fibrillation].

Hnátek T, Zogala D, Kameník L, Kotík I, Jerábek I, Zavoral M.

Vnitr Lek. 2008 Jan;54(1):21-4. Czech.

PMID:
18390113
3.

Male fertility and protein C inhibitor/plasminogen activator inhibitor-3 (PCI): localization of PCI in mouse testis and failure of single plasminogen activator knockout to restore spermatogenesis in PCI-deficient mice.

Uhrin P, Schöfer C, Zaujec J, Ryban L, Hilpert M, Weipoltshammer K, Jerabek I, Pirtzkall I, Furtmüller M, Dewerchin M, Binder BR, Geiger M.

Fertil Steril. 2007 Oct;88(4 Suppl):1049-57. Epub 2007 Apr 16.

PMID:
17434507
4.

Regulation of protein C inhibitor (PCI) activity by specific oxidized and negatively charged phospholipids.

Malleier JM, Oskolkova O, Bochkov V, Jerabek I, Sokolikova B, Perkmann T, Breuss J, Binder BR, Geiger M.

Blood. 2007 Jun 1;109(11):4769-76. Epub 2007 Mar 1.

5.

Binding of retinoic acid by the inhibitory serpin protein C inhibitor.

Jerabek I, Zechmeister-Machhart M, Binder BR, Geiger M.

Eur J Biochem. 2001 Nov;268(22):5989-96.

6.

CCK4-induced panic in healthy subjects II: neurochemical correlates.

Jerabek I, Boulenger JP, Bradwejn J, Drumheller A, Lavallée YJ, Jolicoeur FB.

Eur Neuropsychopharmacol. 1999 Jan;9(1-2):157-64.

PMID:
10082242
7.

CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects.

Jerabek I, Boulenger JP, Bradwejn J, Lavallée YJ, Jolicoeur FB.

Eur Neuropsychopharmacol. 1999 Jan;9(1-2):149-55.

PMID:
10082241
8.

Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic system.

Geiger M, Krebs M, Jerabek I, Binder BR.

Immunopharmacology. 1997 Jun;36(2-3):279-84. Review. No abstract available.

PMID:
9228558
9.

Elevated plasma levels of neuropeptide Y in patients with panic disorder.

Boulenger JP, Jerabek I, Jolicoeur FB, Lavallée YJ, Leduc R, Cadieux A.

Am J Psychiatry. 1996 Jan;153(1):114-6.

PMID:
8540568
10.

Imagined test situations produce contextual memory enhancement.

Jerabek I, Standing L.

Percept Mot Skills. 1992 Oct;75(2):400.

PMID:
1408597
11.

Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.

Ecke S, Geiger M, Resch I, Jerabek I, Sting L, Maier M, Binder BR.

J Biol Chem. 1992 Apr 5;267(10):7048-52.

12.

Possible identity of kallikrein binding protein with protein C inhibitor.

Ecke S, Geiger M, Resch I, Jerabek I, Maier M, Binder BR.

Agents Actions Suppl. 1992;38 ( Pt 1):182-9.

PMID:
1334618
13.

Determination of human low molecular weight kininogen by immunoassay.

Jerabek I, Stetina Z, Furtner R, Binder BR, Maier M.

Agents Actions Suppl. 1992;38 ( Pt 1):257-66.

PMID:
1281608
14.

Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and man.

Maier M, Reissert G, Jerabek I, Bergmann I, Balaun E, Lottspeich F, Binder BR.

Biochem Pharmacol. 1990 Feb 1;39(3):549-53.

PMID:
2306266
15.

Characterization of kinins released from human kininogens by human urinary kallikrein.

Maier M, Reissert G, Jerabek I, Binder BR.

Adv Exp Med Biol. 1989;247A:353-7. No abstract available.

PMID:
2603802
16.

Correlation of two different assays for urinary kallikrein in normotensive and hypertensive subjects.

Maier M, Jerabek I, Reissert G, Höltzl E, Binder BR.

Clin Chim Acta. 1988 Dec 15;178(2):127-39.

PMID:
3242981
17.

Identification of [hydroxyproline3]-lysyl-bradykinin released from human kininogens by human urinary kallikrein.

Maier M, Reissert G, Jerabek I, Lottspeich F, Binder BR.

FEBS Lett. 1988 May 23;232(2):395-8.

Supplemental Content

Loading ...
Support Center